ONTOLOGY REPORT - ANNOTATIONS
| Term: | s-block molecular entity |
|
| Accession: | CHEBI:33674
|
browse the term
|
| Definition: | An s-block molecular entity is a molecular entity containing one or more atoms of an s-block element. |
| Synonyms: | related_synonym: | s-block compounds; s-block molecular entities |
|
|
chloramine T
|
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
multiple interactions |
ISO |
4 |
6,192,644 |
6,224,285 |
RGD:6480464 |
CTD |
| G |
Msra |
methionine sulfoxide reductase A |
|
decreases response to substance |
ISO |
15 |
43,509,775 |
43,756,283 |
RGD:6480464 |
CTD |
| G |
Msra |
methionine sulfoxide reductase A |
|
multiple interactions |
ISO |
15 |
43,509,775 |
43,756,283 |
RGD:6480464 |
CTD |
| G |
Nrgn |
neurogranin |
|
multiple interactions |
EXP |
8 |
38,790,596 |
38,799,077 |
RGD:6480464 |
CTD |
| G |
Nrgn |
neurogranin |
|
affects phosphorylation |
EXP |
8 |
38,790,596 |
38,799,077 |
RGD:6480464 |
CTD |
| G |
Selp |
selectin P |
|
decreases expression |
ISO |
13 |
79,886,614 |
79,922,180 |
RGD:6480464 |
CTD |
disodium cromoglycate
|
| G |
Adora3 |
adenosine A3 receptor |
|
decreases activity |
EXP |
2 |
201,157,782 |
201,161,425 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
multiple interactions |
ISO |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
increases expression |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
multiple interactions |
EXP |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
multiple interactions |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
disodium tetraborate
|
| G |
Sts |
steroid sulfatase (microsomal), isozyme S |
|
decreases activity |
ISO |
X |
63,915,803 |
63,923,834 |
RGD:6480464 |
CTD |
erythrosine sodium
|
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
decreases activity |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
increases activity |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases activity |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
increases expression |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Orm1 |
orosomucoid 1 |
|
increases expression |
ISO |
5 |
80,325,042 |
80,328,194 |
RGD:6480464 |
CTD |
| G |
Phex |
phosphate regulating endopeptidase homolog, X-linked |
|
increases expression |
ISO |
X |
58,911,144 |
59,168,857 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases activity |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Trh |
thyrotropin releasing hormone |
|
multiple interactions |
EXP |
4 |
126,425,212 |
126,427,670 |
RGD:6480464 |
CTD |
| G |
Tshb |
thyroid stimulating hormone, beta |
|
multiple interactions |
EXP |
2 |
197,908,308 |
197,913,186 |
RGD:6480464 |
CTD |
| G |
Ugt1a6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
decreases activity |
ISO |
9 |
87,037,154 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Ugt2b7 |
UDP glucuronosyltransferase 2 family, polypeptide B7 |
|
decreases activity |
ISO |
14 |
22,499,152 |
22,522,842 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
metamizole sodium
|
| G |
Crh |
corticotropin releasing hormone |
|
multiple interactions |
EXP |
2 |
104,764,023 |
104,765,887 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
EXP |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
decreases activity |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
decreases activity |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
multiple interactions |
EXP |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
potassium bromate
|
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
increases expression |
ISO |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
decreases expression |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
increases expression |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccno |
cyclin O |
|
decreases expression |
ISO |
2 |
44,377,953 |
44,381,020 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases phosphorylation |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
increases expression |
EXP |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Ercc4 |
excision repair cross-complementing rodent repair deficiency, complementation group 4 |
|
decreases expression |
ISO |
10 |
2,144,262 |
2,177,554 |
RGD:6480464 |
CTD |
| G |
Fen1 |
flap structure-specific endonuclease 1 |
|
decreases expression |
ISO |
1 |
212,688,118 |
212,692,486 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
increases mutagenesis |
ISO |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
increases mutagenesis |
ISO |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Lig3 |
ligase III, DNA, ATP-dependent |
|
decreases expression |
ISO |
10 |
71,000,287 |
71,021,398 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mutyh |
mutY homolog (E. coli) |
|
decreases expression |
ISO |
5 |
137,103,958 |
137,115,897 |
RGD:6480464 |
CTD |
| G |
Pnkp |
polynucleotide kinase 3'-phosphatase |
|
decreases expression |
ISO |
1 |
95,330,455 |
95,335,468 |
RGD:6480464 |
CTD |
| G |
Srxn1 |
sulfiredoxin 1 |
|
increases expression |
ISO |
3 |
142,457,352 |
142,462,725 |
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1, soluble |
|
increases mutagenesis |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Top3b |
topoisomerase (DNA) III beta |
|
decreases expression |
ISO |
11 |
86,116,936 |
86,145,314 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases phosphorylation |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases phosphorylation |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Xrcc3 |
X-ray repair complementing defective repair in Chinese hamster cells 3 |
|
decreases expression |
ISO |
6 |
136,594,276 |
136,602,069 |
RGD:6480464 |
CTD |
potassium chloride
|
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
multiple interactions |
EXP |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
affects response to substance |
EXP |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
increases phosphorylation |
EXP |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
|
multiple interactions |
EXP |
19 |
41,646,190 |
41,669,234 |
RGD:6480464 |
CTD |
| G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
|
increases phosphorylation |
EXP |
19 |
41,646,190 |
41,669,234 |
RGD:6480464 |
CTD |
| G |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
|
multiple interactions |
ISO |
19 |
25,188,170 |
25,424,495 |
RGD:6480464 |
CTD |
| G |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
|
multiple interactions |
EXP |
19 |
25,188,170 |
25,424,495 |
RGD:6480464 |
CTD |
| G |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
|
multiple interactions |
EXP |
3 |
2,842,948 |
3,039,747 |
RGD:6480464 |
CTD |
| G |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
|
multiple interactions |
ISO |
4 |
154,895,691 |
155,517,389 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
multiple interactions |
ISO |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
multiple interactions |
ISO |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases expression |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases secretion |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases secretion |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases secretion |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases secretion |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases secretion |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases secretion |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases secretion |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Camk2d |
calcium/calmodulin-dependent protein kinase II delta |
|
multiple interactions |
EXP |
2 |
223,840,650 |
224,108,082 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav3 |
caveolin 3 |
|
multiple interactions |
ISO |
4 |
148,294,428 |
148,310,380 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
multiple interactions |
EXP |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
multiple interactions |
EXP |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
decreases expression |
EXP |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Cyp11b1 |
cytochrome P450, family 11, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
112,977,395 |
112,984,080 |
RGD:6480464 |
CTD |
| G |
Cyp11b1 |
cytochrome P450, family 11, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
7 |
112,977,395 |
112,984,080 |
RGD:6480464 |
CTD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
multiple interactions |
ISO |
7 |
113,043,365 |
113,049,779 |
RGD:6480464 |
CTD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
7 |
113,043,365 |
113,049,779 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
EXP |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
multiple interactions |
EXP |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Ednra |
endothelin receptor type A |
|
multiple interactions |
ISO |
19 |
32,042,366 |
32,108,153 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
multiple interactions |
EXP |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
EXP |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
increases expression |
EXP |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
affects expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Gap43 |
growth associated protein 43 |
|
multiple interactions |
EXP |
11 |
59,989,085 |
60,083,971 |
RGD:6480464 |
CTD |
| G |
Gap43 |
growth associated protein 43 |
|
increases expression |
EXP |
11 |
59,989,085 |
60,083,971 |
RGD:6480464 |
CTD |
| G |
Gnas |
GNAS complex locus |
|
multiple interactions |
EXP |
3 |
165,213,399 |
165,214,551 |
RGD:6480464 |
CTD |
| G |
Gpd2 |
glycerol-3-phosphate dehydrogenase 2, mitochondrial |
|
multiple interactions |
ISO |
3 |
38,980,634 |
39,114,492 |
RGD:6480464 |
CTD |
| G |
Grin2d |
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
|
decreases expression |
ISO |
1 |
96,308,548 |
96,345,931 |
RGD:6480464 |
CTD |
| G |
Hdac5 |
histone deacetylase 5 |
|
multiple interactions |
ISO |
10 |
91,266,512 |
91,277,705 |
RGD:6480464 |
CTD |
| G |
Hdac5 |
histone deacetylase 5 |
|
increases phosphorylation |
ISO |
10 |
91,266,512 |
91,277,705 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases response to substance |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
|
affects response to substance |
EXP |
10 |
87,822,429 |
87,834,315 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
affects response to substance |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
increases secretion |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
increases secretion |
ISO |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
multiple interactions |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
increases expression |
EXP |
4 |
143,705,360 |
144,030,051 |
RGD:6480464 |
CTD |
| G |
Kcna1 |
potassium voltage-gated channel, shaker-related subfamily, member 1 |
|
multiple interactions |
EXP |
4 |
163,011,777 |
163,013,522 |
RGD:6480464 |
CTD |
| G |
Kcna1 |
potassium voltage-gated channel, shaker-related subfamily, member 1 |
|
increases expression |
EXP |
4 |
163,011,777 |
163,013,522 |
RGD:6480464 |
CTD |
| G |
Kcna4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
|
increases expression |
EXP |
3 |
92,781,795 |
92,784,921 |
RGD:6480464 |
CTD |
| G |
Kcnc1 |
potassium voltage gated channel, Shaw-related subfamily, member 1 |
|
decreases expression |
EXP |
1 |
96,928,275 |
96,970,062 |
RGD:6480464 |
CTD |
| G |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
|
increases expression |
EXP |
1 |
95,066,641 |
95,080,847 |
RGD:6480464 |
CTD |
| G |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
|
multiple interactions |
EXP |
1 |
95,066,641 |
95,080,847 |
RGD:6480464 |
CTD |
| G |
Kcnd2 |
potassium voltage-gated channel, Shal-related subfamily, member 2 |
|
increases expression |
EXP |
4 |
47,541,787 |
48,047,924 |
RGD:6480464 |
CTD |
| G |
Klk8 |
kallikrein related-peptidase 8 |
|
increases activity |
ISO |
1 |
94,227,185 |
94,234,028 |
RGD:6480464 |
CTD |
| G |
Kng1 |
kininogen 1 |
|
multiple interactions |
EXP |
11 |
80,109,499 |
80,131,887 |
RGD:6480464 |
CTD |
| G |
Kng1 |
kininogen 1 |
|
multiple interactions |
EXP |
11 |
80,109,499 |
80,131,887 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases response to substance |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk10 |
mitogen activated protein kinase 10 |
|
multiple interactions |
ISO |
14 |
7,719,595 |
8,010,694 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
multiple interactions |
EXP |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
decreases phosphorylation |
EXP |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
affects response to substance |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases response to substance |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Npy |
neuropeptide Y |
|
increases expression |
EXP |
4 |
78,038,013 |
78,045,187 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
EXP |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
increases expression |
EXP |
3 |
38,866,205 |
38,871,678 |
RGD:6480464 |
CTD |
| G |
Nrf1 |
nuclear respiratory factor 1 |
|
increases expression |
EXP |
4 |
56,949,553 |
57,048,149 |
RGD:6480464 |
CTD |
| G |
Nrxn2 |
neurexin 2 |
|
decreases expression |
EXP |
1 |
209,211,740 |
209,318,064 |
RGD:6480464 |
CTD |
| G |
Nrxn3 |
neurexin 3 |
|
increases expression |
EXP |
6 |
112,273,955 |
113,905,437 |
RGD:6480464 |
CTD |
| G |
Pkd1 |
polycystic kidney disease 1 homolog (human) |
|
affects response to substance |
ISO |
10 |
13,801,445 |
13,848,212 |
RGD:6480464 |
CTD |
| G |
Pld2 |
phospholipase D2 |
|
multiple interactions |
EXP |
10 |
57,388,474 |
57,439,063 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
EXP |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppp1r12a |
protein phosphatase 1, regulatory subunit 12A |
|
multiple interactions |
EXP |
7 |
46,876,552 |
46,986,022 |
RGD:6480464 |
CTD |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
multiple interactions |
EXP |
15 |
45,589,222 |
45,717,866 |
RGD:6480464 |
CTD |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
increases phosphorylation |
EXP |
15 |
45,589,222 |
45,717,866 |
RGD:6480464 |
CTD |
| G |
Rapgef4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
|
decreases expression |
EXP |
3 |
54,396,312 |
54,717,148 |
RGD:6480464 |
CTD |
| G |
Scg2 |
secretogranin II |
|
increases expression |
EXP |
9 |
78,762,661 |
78,767,970 |
RGD:6480464 |
CTD |
| G |
Scn10a |
sodium channel, voltage-gated, type X, alpha subunit |
|
multiple interactions |
ISO |
8 |
124,578,222 |
124,690,458 |
RGD:6480464 |
CTD |
| G |
Sct |
secretin |
|
multiple interactions |
EXP |
1 |
201,472,250 |
201,472,944 |
RGD:6480464 |
CTD |
| G |
Sct |
secretin |
|
increases secretion |
EXP |
1 |
201,472,250 |
201,472,944 |
RGD:6480464 |
CTD |
| G |
Sct |
secretin |
|
multiple interactions |
EXP |
1 |
201,472,250 |
201,472,944 |
RGD:6480464 |
CTD |
| G |
Sct |
secretin |
|
multiple interactions |
EXP |
1 |
201,472,250 |
201,472,944 |
RGD:6480464 |
CTD |
| G |
Sct |
secretin |
|
increases secretion |
EXP |
1 |
201,472,250 |
201,472,944 |
RGD:6480464 |
CTD |
| G |
Sct |
secretin |
|
multiple interactions |
EXP |
1 |
201,472,250 |
201,472,944 |
RGD:6480464 |
CTD |
| G |
Sct |
secretin |
|
increases secretion |
EXP |
1 |
201,472,250 |
201,472,944 |
RGD:6480464 |
CTD |
| G |
Slc12a5 |
solute carrier family 12 (potassium-chloride transporter), member 5 |
|
increases expression |
EXP |
3 |
156,006,017 |
156,037,915 |
RGD:6480464 |
CTD |
| G |
Slc30a8 |
solute carrier family 30 (zinc transporter), member 8 |
|
multiple interactions |
EXP |
7 |
88,583,770 |
88,617,145 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions |
EXP |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
increases phosphorylation |
EXP |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Syn1 |
synapsin I |
|
multiple interactions |
EXP |
X |
12,512,241 |
12,556,160 |
RGD:6480464 |
CTD |
| G |
Syn1 |
synapsin I |
|
increases expression |
EXP |
X |
12,512,241 |
12,556,160 |
RGD:6480464 |
CTD |
| G |
Syt5 |
synaptotagmin V |
|
increases expression |
EXP |
1 |
68,005,337 |
68,013,052 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
increases secretion |
ISO |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
multiple interactions |
ISO |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
multiple interactions |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
multiple interactions |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
increases secretion |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
increases expression |
ISO |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
multiple interactions |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
increases secretion |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
increases secretion |
EXP |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tfam |
transcription factor A, mitochondrial |
|
increases expression |
EXP |
20 |
18,100,629 |
18,112,682 |
RGD:6480464 |
CTD |
| G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
|
multiple interactions |
EXP |
9 |
87,193,779 |
87,278,440 |
RGD:6480464 |
CTD |
| G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
|
increases activity |
EXP |
9 |
87,193,779 |
87,278,440 |
RGD:6480464 |
CTD |
| G |
Unc13c |
unc-13 homolog C (C. elegans) |
|
decreases expression |
EXP |
8 |
78,278,728 |
78,703,566 |
RGD:6480464 |
CTD |
potassium dichromate
|
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
increases expression |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Acat1 |
acetyl-CoA acetyltransferase 1 |
|
increases expression |
ISO |
8 |
57,044,478 |
57,072,970 |
RGD:6480464 |
CTD |
| G |
Acp2 |
acid phosphatase 2, lysosomal |
|
decreases expression |
ISO |
3 |
75,559,522 |
75,568,415 |
RGD:6480464 |
CTD |
| G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
decreases expression |
ISO |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
increases expression |
ISO |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Akr1b1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
|
decreases expression |
ISO |
4 |
61,645,438 |
61,659,530 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
decreases activity |
EXP |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
increases expression |
ISO |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
increases expression |
ISO |
14 |
14,245,112 |
14,297,100 |
RGD:6480464 |
CTD |
| G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
|
increases expression |
ISO |
4 |
32,758,866 |
32,776,220 |
RGD:6480464 |
CTD |
| G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
|
decreases expression |
ISO |
7 |
36,493,661 |
36,600,280 |
RGD:6480464 |
CTD |
| G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
|
decreases expression |
ISO |
12 |
17,492,913 |
17,498,949 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
decreases phosphorylation |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
affects localization |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
affects localization |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
|
increases expression |
ISO |
4 |
144,139,486 |
144,145,186 |
RGD:6480464 |
CTD |
| G |
Calr |
calreticulin |
|
decreases expression |
ISO |
19 |
24,964,775 |
24,969,670 |
RGD:6480464 |
CTD |
| G |
Canx |
calnexin |
|
increases expression |
ISO |
10 |
35,850,944 |
35,883,494 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccbl1 |
cysteine conjugate-beta lyase, cytoplasmic |
|
increases expression |
EXP |
3 |
9,195,737 |
9,209,545 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
increases secretion |
ISO |
9 |
82,440,965 |
82,443,542 |
RGD:6480464 |
CTD |
| G |
Ccl27 |
chemokine (C-C motif) ligand 27 |
|
increases secretion |
ISO |
5 |
59,199,779 |
59,204,297 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
increases expression |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
ISO |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Cct2 |
chaperonin containing TCP1, subunit 2 (beta) |
|
increases expression |
ISO |
7 |
56,391,341 |
56,404,084 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cfb |
complement factor B |
|
decreases expression |
ISO |
20 |
4,072,124 |
4,077,802 |
RGD:6480464 |
CTD |
| G |
Chst3 |
carbohydrate (chondroitin 6) sulfotransferase 3 |
|
increases expression |
ISO |
20 |
27,480,448 |
27,482,990 |
RGD:6480464 |
CTD |
| G |
Cldn2 |
claudin 2 |
|
multiple interactions |
EXP |
X |
127,538,685 |
127,549,019 |
RGD:6480464 |
CTD |
| G |
Cldn2 |
claudin 2 |
|
affects localization |
EXP |
X |
127,538,685 |
127,549,019 |
RGD:6480464 |
CTD |
| G |
Clgn |
calmegin |
|
decreases expression |
ISO |
19 |
26,404,126 |
26,436,081 |
RGD:6480464 |
CTD |
| G |
Clptm1 |
cleft lip and palate associated transmembrane protein 1 |
|
decreases expression |
ISO |
1 |
78,938,917 |
78,970,676 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
decreases expression |
ISO |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
increases expression |
ISO |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Cryaa |
crystallin, alpha A |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
decreases expression |
ISO |
19 |
10,666,940 |
10,676,424 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
increases expression |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
increases expression |
ISO |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
increases expression |
ISO |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Dhfr |
dihydrofolate reductase |
|
increases expression |
ISO |
2 |
22,607,093 |
22,828,487 |
RGD:6480464 |
CTD |
| G |
Dnaja1 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
increases expression |
ISO |
5 |
58,100,794 |
58,111,705 |
RGD:6480464 |
CTD |
| G |
Dnaja2 |
DnaJ (Hsp40) homolog, subfamily A, member 2 |
|
increases expression |
ISO |
19 |
22,853,702 |
22,871,846 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
increases expression |
ISO |
1 |
21,223,678 |
21,287,411 |
RGD:6480464 |
CTD |
| G |
F5 |
coagulation factor V (proaccelerin, labile factor) |
|
decreases expression |
ISO |
13 |
79,934,956 |
79,997,285 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
increases expression |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Furin |
furin (paired basic amino acid cleaving enzyme) |
|
decreases expression |
ISO |
1 |
136,209,969 |
136,222,057 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Ggcx |
gamma-glutamyl carboxylase |
|
decreases expression |
ISO |
4 |
105,719,323 |
105,735,037 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gper |
G protein-coupled estrogen receptor 1 |
|
decreases expression |
ISO |
12 |
15,718,615 |
15,719,893 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
increases expression |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
increases expression |
EXP |
10 |
31,834,519 |
31,858,019 |
RGD:6480464 |
CTD |
| G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
increases expression |
EXP |
10 |
31,834,519 |
31,858,019 |
RGD:6480464 |
CTD |
| G |
Hmga1 |
high mobility group AT-hook 1 |
|
increases expression |
ISO |
20 |
5,769,052 |
5,772,269 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
decreases expression |
ISO |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
decreases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnrnph2 |
heterogeneous nuclear ribonucleoprotein H2 (H') |
|
decreases expression |
ISO |
X |
122,056,647 |
122,061,844 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta, member 1 |
|
increases expression |
ISO |
7 |
23,332,986 |
23,347,525 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
decreases expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
decreases phosphorylation |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
increases expression |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Ier2 |
immediate early response 2 |
|
increases expression |
ISO |
19 |
25,159,276 |
25,160,800 |
RGD:6480464 |
CTD |
| G |
Il17rb |
interleukin 17 receptor B |
|
decreases expression |
ISO |
16 |
5,335,806 |
5,349,160 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases secretion |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il4r |
interleukin 4 receptor |
|
increases expression |
ISO |
1 |
184,612,903 |
184,637,863 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Itgb3bp |
integrin beta 3 binding protein (beta3-endonexin) |
|
increases expression |
ISO |
5 |
120,459,569 |
120,525,476 |
RGD:6480464 |
CTD |
| G |
Itih3 |
inter-alpha trypsin inhibitor, heavy chain 3 |
|
decreases expression |
ISO |
16 |
6,341,043 |
6,358,767 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
multiple interactions |
ISO |
8 |
20,259,178 |
20,266,351 |
RGD:6480464 |
CTD |
| G |
Klf10 |
Kruppel-like factor 10 |
|
increases expression |
ISO |
7 |
73,821,190 |
73,826,866 |
RGD:6480464 |
CTD |
| G |
Lck |
lymphocyte-specific protein tyrosine kinase |
|
multiple interactions |
ISO |
5 |
148,707,505 |
148,718,296 |
RGD:6480464 |
CTD |
| G |
LOC100360316 |
hypothetical protein LOC100360316 |
|
increases expression |
ISO |
16 |
33,979,260 |
33,979,532 |
RGD:6480464 |
CTD |
| G |
Lta |
lymphotoxin alpha (TNF superfamily, member 1) |
|
increases expression |
ISO |
20 |
3,657,842 |
3,659,848 |
RGD:6480464 |
CTD |
| G |
Maff |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
|
increases expression |
ISO |
7 |
117,328,924 |
117,340,276 |
RGD:6480464 |
CTD |
| G |
Manf |
mesencephalic astrocyte-derived neurotrophic factor |
|
decreases expression |
ISO |
8 |
112,111,358 |
112,113,311 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases activity |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
affects localization |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases activity |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
affects localization |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mcm2 |
minichromosome maintenance complex component 2 |
|
increases expression |
ISO |
4 |
122,977,522 |
122,991,934 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
multiple interactions |
EXP |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
decreases expression |
EXP |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mgat2 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
|
decreases expression |
ISO |
6 |
91,137,262 |
91,139,751 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
increases expression |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
increases expression |
EXP |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
decreases response to substance |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases activity |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases phosphorylation |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nnmt |
nicotinamide N-methyltransferase |
|
increases expression |
ISO |
8 |
51,871,506 |
51,883,785 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
|
decreases expression |
ISO |
5 |
151,524,685 |
151,528,000 |
RGD:6480464 |
CTD |
| G |
Nucb2 |
nucleobindin 2 |
|
decreases expression |
ISO |
1 |
174,605,677 |
174,642,111 |
RGD:6480464 |
CTD |
| G |
Ocln |
occludin |
|
increases expression |
EXP |
2 |
31,317,090 |
31,367,485 |
RGD:6480464 |
CTD |
| G |
Os9 |
osteosarcoma amplified 9 |
|
decreases expression |
ISO |
7 |
67,046,802 |
67,073,355 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
EXP |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
|
decreases expression |
ISO |
4 |
75,929,398 |
75,948,299 |
RGD:6480464 |
CTD |
| G |
Pgc |
progastricsin (pepsinogen C) |
|
decreases expression |
ISO |
9 |
8,723,620 |
8,731,837 |
RGD:6480464 |
CTD |
| G |
Pgf |
placental growth factor |
|
decreases expression |
ISO |
6 |
109,215,540 |
109,226,122 |
RGD:6480464 |
CTD |
| G |
Pim1 |
pim-1 oncogene |
|
increases expression |
ISO |
20 |
7,817,403 |
7,821,800 |
RGD:6480464 |
CTD |
| G |
Pkm |
pyruvate kinase, muscle |
|
increases expression |
ISO |
8 |
63,486,492 |
63,508,016 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
| G |
Pnma1 |
paraneoplastic Ma antigen 1 |
|
decreases expression |
ISO |
6 |
108,198,611 |
108,200,396 |
RGD:6480464 |
CTD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
increases expression |
ISO |
14 |
64,278,115 |
64,370,912 |
RGD:6480464 |
CTD |
| G |
Ppih |
peptidylprolyl isomerase H (cyclophilin H) |
|
increases expression |
ISO |
5 |
139,959,365 |
139,969,320 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
increases expression |
ISO |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Psme3 |
proteasome (prosome, macropain) activator subunit 3 |
|
increases expression |
ISO |
10 |
90,343,493 |
90,351,335 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
increases expression |
ISO |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming 1 |
|
increases expression |
ISO |
10 |
28,527,409 |
28,532,831 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases phosphorylation |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Repin1 |
replication initiator 1 |
|
decreases expression |
ISO |
4 |
76,688,429 |
76,690,141 |
RGD:6480464 |
CTD |
| G |
Rfc2 |
replication factor C (activator 1) 2 |
|
increases expression |
ISO |
12 |
23,185,550 |
23,198,655 |
RGD:6480464 |
CTD |
| G |
RGD1310769 |
similar to HSPC288 |
|
decreases expression |
ISO |
6 |
109,934,787 |
109,945,923 |
RGD:6480464 |
CTD |
| G |
Rgn |
regucalcin (senescence marker protein-30) |
|
decreases expression |
EXP |
X |
13,037,171 |
13,052,846 |
RGD:6480464 |
CTD |
| G |
Rnaseh2a |
ribonuclease H2, subunit A |
|
increases expression |
ISO |
19 |
24,841,614 |
24,851,834 |
RGD:6480464 |
CTD |
| G |
Serpinb1a |
serine (or cysteine) proteinase inhibitor, clade B, member 1a |
|
decreases expression |
ISO |
17 |
37,950,875 |
37,959,284 |
RGD:6480464 |
CTD |
| G |
Serpinc1 |
serpin peptidase inhibitor, clade C (antithrombin), member 1 |
|
decreases expression |
ISO |
13 |
76,548,456 |
76,562,724 |
RGD:6480464 |
CTD |
| G |
Serpinh1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
|
decreases expression |
ISO |
1 |
156,666,914 |
156,674,210 |
RGD:6480464 |
CTD |
| G |
Sik1 |
salt-inducible kinase 1 |
|
increases expression |
ISO |
20 |
10,282,203 |
10,291,735 |
RGD:6480464 |
CTD |
| G |
Snrpa |
small nuclear ribonucleoprotein polypeptide A |
|
increases expression |
ISO |
1 |
82,265,660 |
82,274,283 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Srsf2 |
serine/arginine-rich splicing factor 2 |
|
increases expression |
ISO |
10 |
106,954,365 |
106,956,807 |
RGD:6480464 |
CTD |
| G |
Srsf5 |
serine/arginine-rich splicing factor 5 |
|
decreases expression |
ISO |
6 |
104,728,286 |
104,732,982 |
RGD:6480464 |
CTD |
| G |
Srsf7 |
serine/arginine-rich splicing factor 7 |
|
increases expression |
ISO |
6 |
3,101,772 |
3,104,433 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
multiple interactions |
ISO |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Taf7 |
TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
decreases expression |
ISO |
18 |
30,541,432 |
30,543,580 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
decreases expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tob1 |
transducer of ErbB-2.1 |
|
decreases expression |
ISO |
10 |
82,852,405 |
82,854,443 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases localization |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
increases expression |
ISO |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
|
increases expression |
ISO |
3 |
155,800,357 |
155,802,757 |
RGD:6480464 |
CTD |
| G |
Ugcg |
UDP-glucose ceramide glucosyltransferase |
|
increases expression |
ISO |
5 |
77,263,334 |
77,295,794 |
RGD:6480464 |
CTD |
potassium hexacyanoferrate(3-)
|
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
potassium iodide
|
| G |
Odc1 |
ornithine decarboxylase 1 |
|
multiple interactions |
EXP |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
potassium nitrate
|
| G |
Ccdc120 |
coiled-coil domain containing 120 |
|
decreases expression |
ISO |
X |
26,804,333 |
26,810,830 |
RGD:6480464 |
CTD |
| G |
Clk1 |
CDC-like kinase 1 |
|
decreases expression |
ISO |
9 |
57,070,825 |
57,082,043 |
RGD:6480464 |
CTD |
| G |
Dclre1c |
DNA cross-link repair 1C |
|
increases expression |
ISO |
17 |
85,896,581 |
85,928,644 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
increases expression |
ISO |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Ftl |
ferritin, light polypeptide |
|
increases expression |
ISO |
1 |
95,929,248 |
95,931,092 |
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmgb2 |
high mobility group box 2 |
|
increases expression |
ISO |
16 |
36,131,304 |
36,133,878 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Sept7 |
septin 7 |
|
decreases expression |
ISO |
8 |
24,924,747 |
24,988,221 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
increases expression |
ISO |
5 |
153,226,420 |
153,232,084 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
rabeprazole sodium
|
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
multiple interactions |
ISO |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Pomc |
proopiomelanocortin |
|
increases expression |
ISO |
6 |
26,931,969 |
26,937,789 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
multiple interactions |
EXP |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
sodium acetate trihydrate
|
| G |
Apob |
apolipoprotein B |
|
multiple interactions |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
sodium aurothiomalate
|
| G |
Cd28 |
Cd28 molecule |
|
multiple interactions |
ISO |
9 |
59,342,273 |
59,367,743 |
RGD:6480464 |
CTD |
| G |
Cd28 |
Cd28 molecule |
|
affects response to substance |
ISO |
9 |
59,342,273 |
59,367,743 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
multiple interactions |
ISO |
1 |
249,122,845 |
249,158,369 |
RGD:6480464 |
CTD |
| G |
Fbl |
fibrillarin |
|
affects localization |
ISO |
1 |
83,271,967 |
83,281,069 |
RGD:6480464 |
CTD |
| G |
Fbl |
fibrillarin |
|
multiple interactions |
ISO |
1 |
83,271,967 |
83,281,069 |
RGD:6480464 |
CTD |
| G |
Fbl |
fibrillarin |
|
decreases activity |
ISO |
1 |
83,271,967 |
83,281,069 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
affects response to substance |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
multiple interactions |
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
multiple interactions |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
affects response to substance |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
affects response to substance |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
multiple interactions |
ISO |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
decreases activity |
EXP |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Txnrd2 |
thioredoxin reductase 2 |
|
decreases activity |
EXP |
11 |
84,513,361 |
84,561,673 |
RGD:6480464 |
CTD |
sodium azide
|
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Atp8b1 |
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
|
multiple interactions |
EXP |
18 |
60,748,738 |
60,829,650 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
affects localization |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
decreases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
multiple interactions |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cirbp |
cold inducible RNA binding protein |
|
decreases expression |
ISO |
7 |
11,047,003 |
11,050,820 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
multiple interactions |
ISO |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Dao |
D-amino-acid oxidase |
|
decreases activity |
ISO |
12 |
43,627,593 |
43,648,332 |
RGD:6480464 |
CTD |
| G |
Duox2 |
dual oxidase 2 |
|
multiple interactions |
ISO |
3 |
109,059,360 |
109,077,106 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Elavl1 |
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) |
|
multiple interactions |
ISO |
12 |
1,459,046 |
1,500,042 |
RGD:6480464 |
CTD |
| G |
Elavl1 |
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) |
|
decreases localization |
ISO |
12 |
1,459,046 |
1,500,042 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
affects expression |
EXP |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Kcnj12 |
potassium inwardly-rectifying channel, subfamily J, member 12 |
|
multiple interactions |
ISO |
10 |
47,169,007 |
47,215,218 |
RGD:6480464 |
CTD |
| G |
Kcnj4 |
potassium inwardly-rectifying channel, subfamily J, member 4 |
|
multiple interactions |
ISO |
7 |
117,601,723 |
117,616,019 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
ISO |
8 |
4,333,773 |
4,354,284 |
RGD:6480464 |
CTD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
multiple interactions |
ISO |
8 |
4,315,601 |
4,329,146 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Mt-co3 |
mitochondrially encoded cytochrome c oxidase III |
|
multiple interactions |
ISO |
MT |
8,599 |
9,382 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Ppp1ca |
protein phosphatase 1, catalytic subunit, alpha isozyme |
|
decreases expression |
EXP |
1 |
206,774,719 |
206,778,336 |
RGD:6480464 |
CTD |
| G |
Ppp1cc |
protein phosphatase 1, catalytic subunit, gamma isozyme |
|
decreases expression |
EXP |
12 |
35,580,169 |
35,598,249 |
RGD:6480464 |
CTD |
| G |
Psen2 |
presenilin 2 |
|
decreases expression |
ISO |
13 |
95,934,674 |
95,951,836 |
RGD:6480464 |
CTD |
| G |
Rbm3 |
RNA binding motif (RNP1, RRM) protein 3 |
|
decreases expression |
ISO |
X |
26,379,303 |
26,382,739 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
increases expression |
ISO |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
increases expression |
ISO |
10 |
56,786,705 |
56,792,209 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Txn2 |
thioredoxin 2 |
|
affects expression |
ISO |
7 |
115,833,695 |
115,847,690 |
RGD:6480464 |
CTD |
| G |
Txn2 |
thioredoxin 2 |
|
multiple interactions |
ISO |
7 |
115,833,695 |
115,847,690 |
RGD:6480464 |
CTD |
sodium chloride
|
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
multiple interactions |
ISO |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
multiple interactions |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc4 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 4 |
|
multiple interactions |
ISO |
15 |
103,384,848 |
103,611,238 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
multiple interactions |
ISO |
10 |
95,361,338 |
95,381,455 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
decreases expression |
EXP |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
multiple interactions |
EXP |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
increases expression |
ISO |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Avp |
arginine vasopressin |
|
increases expression |
EXP |
3 |
118,205,007 |
118,206,985 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
multiple interactions |
EXP |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
multiple interactions |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
increases expression |
EXP |
1 |
172,686,168 |
172,691,061 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
EXP |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
increases expression |
EXP |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
multiple interactions |
EXP |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
increases activity |
EXP |
7 |
113,043,365 |
113,049,779 |
RGD:6480464 |
CTD |
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
increases expression |
EXP |
7 |
113,043,365 |
113,049,779 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Ednra |
endothelin receptor type A |
|
multiple interactions |
ISO |
19 |
32,042,366 |
32,108,153 |
RGD:6480464 |
CTD |
| G |
Ednra |
endothelin receptor type A |
|
multiple interactions |
EXP |
19 |
32,042,366 |
32,108,153 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
multiple interactions |
EXP |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases phosphorylation |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
increases expression |
EXP |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
increases expression |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
decreases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gja5 |
gap junction protein, alpha 5 |
|
multiple interactions |
ISO |
2 |
191,824,118 |
191,843,867 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
increases expression |
EXP |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
EXP |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
decreases activity |
EXP |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
decreases expression |
EXP |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Kcnj1 |
potassium inwardly-rectifying channel, subfamily J, member 1 |
|
decreases expression |
ISO |
8 |
32,158,243 |
32,162,370 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Nfat5 |
nuclear factor of activated T-cells 5, tonicity-responsive |
|
multiple interactions |
ISO |
19 |
37,154,326 |
37,242,191 |
RGD:6480464 |
CTD |
| G |
Nfat5 |
nuclear factor of activated T-cells 5, tonicity-responsive |
|
increases activity |
ISO |
19 |
37,154,326 |
37,242,191 |
RGD:6480464 |
CTD |
| G |
Nfat5 |
nuclear factor of activated T-cells 5, tonicity-responsive |
|
multiple interactions |
ISO |
19 |
37,154,326 |
37,242,191 |
RGD:6480464 |
CTD |
| G |
Nfat5 |
nuclear factor of activated T-cells 5, tonicity-responsive |
|
affects localization |
ISO |
19 |
37,154,326 |
37,242,191 |
RGD:6480464 |
CTD |
| G |
Nfat5 |
nuclear factor of activated T-cells 5, tonicity-responsive |
|
increases expression |
ISO |
19 |
37,154,326 |
37,242,191 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
increases expression |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nox1 |
NADPH oxidase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
multiple interactions |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases expression |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nup88 |
nucleoporin 88 |
|
increases expression |
ISO |
10 |
57,849,428 |
57,874,078 |
RGD:6480464 |
CTD |
| G |
Ppp1r12a |
protein phosphatase 1, regulatory subunit 12A |
|
multiple interactions |
EXP |
7 |
46,876,552 |
46,986,022 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
increases activity |
ISO |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
multiple interactions |
EXP |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
multiple interactions |
EXP |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases expression |
EXP |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
multiple interactions |
EXP |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases expression |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
multiple interactions |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
multiple interactions |
EXP |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases expression |
EXP |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases activity |
EXP |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
multiple interactions |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Scnn1a |
sodium channel, nonvoltage-gated 1 alpha |
|
multiple interactions |
EXP |
4 |
161,445,936 |
161,469,267 |
RGD:6480464 |
CTD |
| G |
Scnn1a |
sodium channel, nonvoltage-gated 1 alpha |
|
increases expression |
EXP |
4 |
161,445,936 |
161,469,267 |
RGD:6480464 |
CTD |
| G |
Slc10a1 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
|
multiple interactions |
ISO |
6 |
104,735,839 |
104,749,464 |
RGD:6480464 |
CTD |
| G |
Slc12a1 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 1 |
|
affects transport |
ISO |
3 |
112,455,897 |
112,534,752 |
RGD:6480464 |
CTD |
| G |
Slc12a1 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 1 |
|
decreases expression |
ISO |
3 |
112,455,897 |
112,534,752 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
increases expression |
ISO |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc6a12 |
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
|
increases expression |
ISO |
4 |
157,781,178 |
157,800,038 |
RGD:6480464 |
CTD |
| G |
Slc6a12 |
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
|
multiple interactions |
ISO |
4 |
157,781,178 |
157,800,038 |
RGD:6480464 |
CTD |
| G |
Slc9a1 |
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
|
multiple interactions |
ISO |
5 |
151,680,696 |
151,748,460 |
RGD:6480464 |
CTD |
| G |
Slc9a3 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 |
|
multiple interactions |
ISO |
1 |
29,930,908 |
29,973,686 |
RGD:6480464 |
CTD |
| G |
Slc9b2 |
solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2 |
|
affects abundance |
ISO |
2 |
232,789,603 |
232,833,880 |
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
multiple interactions |
ISO |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
multiple interactions |
ISO |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
multiple interactions |
ISO |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
increases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
multiple interactions |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
affects response to substance |
ISO |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
increases expression |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
affects response to substance |
EXP |
10 |
60,109,656 |
60,134,939 |
RGD:6480464 |
CTD |
sodium cholate
|
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
sodium dichromate
|
| G |
A2m |
alpha-2-macroglobulin |
|
affects expression |
EXP |
4 |
158,103,711 |
158,153,423 |
RGD:6480464 |
CTD |
| G |
Abca8 |
ATP-binding cassette, subfamily A (ABC1), member 8 |
|
affects expression |
EXP |
10 |
99,392,053 |
99,452,833 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 6 |
|
affects expression |
EXP |
1 |
96,448,588 |
96,524,655 |
RGD:6480464 |
CTD |
| G |
Abcg5 |
ATP-binding cassette, subfamily G (WHITE), member 5 |
|
affects expression |
EXP |
6 |
8,027,647 |
8,064,425 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
affects expression |
EXP |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsm2a |
acyl-CoA synthetase medium-chain family member 2A |
|
affects expression |
EXP |
1 |
177,830,613 |
177,869,061 |
RGD:6480464 |
CTD |
| G |
Adk |
adenosine kinase |
|
affects expression |
EXP |
15 |
3,071,412 |
3,458,891 |
RGD:6480464 |
CTD |
| G |
Agmo |
alkylglycerol monooxygenase |
|
affects expression |
EXP |
6 |
56,042,873 |
56,380,045 |
RGD:6480464 |
CTD |
| G |
Akr1b7 |
aldo-keto reductase family 1, member B7 |
|
affects expression |
EXP |
4 |
61,794,352 |
61,806,916 |
RGD:6480464 |
CTD |
| G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
|
affects expression |
EXP |
4 |
61,714,282 |
61,726,856 |
RGD:6480464 |
CTD |
| G |
Akr1d1 |
aldo-keto reductase family 1, member D1 |
|
affects expression |
EXP |
4 |
64,972,908 |
65,005,896 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases expression |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
|
affects expression |
EXP |
5 |
62,311,268 |
62,316,276 |
RGD:6480464 |
CTD |
| G |
Aldob |
aldolase B, fructose-bisphosphate |
|
affects expression |
EXP |
5 |
66,283,165 |
66,296,171 |
RGD:6480464 |
CTD |
| G |
Ampd3 |
adenosine monophosphate deaminase 3 |
|
affects expression |
EXP |
1 |
168,519,462 |
168,568,291 |
RGD:6480464 |
CTD |
| G |
Anxa6 |
annexin A6 |
|
affects expression |
EXP |
10 |
40,383,975 |
40,439,683 |
RGD:6480464 |
CTD |
| G |
Anxa8 |
annexin A8 |
|
affects expression |
EXP |
16 |
9,715,644 |
9,730,584 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
affects expression |
EXP |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
affects expression |
EXP |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Arhgap11a |
Rho GTPase activating protein 11A |
|
affects expression |
EXP |
3 |
99,676,951 |
99,693,232 |
RGD:6480464 |
CTD |
| G |
Arsa |
arylsulfatase A |
|
affects expression |
EXP |
7 |
127,790,208 |
127,792,734 |
RGD:6480464 |
CTD |
| G |
As3mt |
arsenic (+3 oxidation state) methyltransferase |
|
affects expression |
EXP |
1 |
252,029,638 |
252,061,352 |
RGD:6480464 |
CTD |
| G |
Asf1b |
ASF1 anti-silencing function 1 homolog B (S. cerevisiae) |
|
affects expression |
EXP |
19 |
25,867,384 |
25,881,909 |
RGD:6480464 |
CTD |
| G |
Atad5 |
ATPase family, AAA domain containing 5 |
|
affects expression |
EXP |
10 |
68,292,360 |
68,339,430 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
affects expression |
EXP |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 (tax-responsive enhancer element B67) |
|
increases expression |
ISO |
7 |
118,537,718 |
118,538,994 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
decreases expression |
ISO |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp6v0a1 |
ATPase, H+ transporting, lysosomal V0 subunit A1 |
|
affects expression |
EXP |
10 |
89,948,286 |
90,072,304 |
RGD:6480464 |
CTD |
| G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
|
affects expression |
EXP |
12 |
17,492,913 |
17,498,949 |
RGD:6480464 |
CTD |
| G |
Baat |
bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) |
|
affects expression |
EXP |
5 |
66,245,786 |
66,254,757 |
RGD:6480464 |
CTD |
| G |
Bbs9 |
Bardet-Biedl syndrome 9 |
|
affects expression |
EXP |
8 |
22,231,570 |
22,542,713 |
RGD:6480464 |
CTD |
| G |
Bcas3 |
breast carcinoma amplified sequence 3 |
|
affects expression |
EXP |
10 |
73,617,547 |
74,078,190 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcs1l |
BC1 (ubiquinol-cytochrome c reductase) synthesis-like |
|
affects expression |
EXP |
9 |
73,939,024 |
73,943,055 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
increases cleavage |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
decreases expression |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Bucs1 |
butyryl Coenzyme A synthetase 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
C8b |
complement component 8, beta polypeptide |
|
affects expression |
EXP |
5 |
125,728,606 |
125,766,093 |
RGD:6480464 |
CTD |
| G |
C8g |
complement component 8, gamma polypeptide |
|
affects expression |
EXP |
3 |
3,671,282 |
3,674,282 |
RGD:6480464 |
CTD |
| G |
C9 |
complement component 9 |
|
affects expression |
EXP |
2 |
55,743,084 |
55,791,148 |
RGD:6480464 |
CTD |
| G |
Cacna1d |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
|
affects expression |
EXP |
16 |
5,383,259 |
5,703,361 |
RGD:6480464 |
CTD |
| G |
Calml4 |
calmodulin-like 4 |
|
affects expression |
EXP |
8 |
67,007,122 |
67,018,886 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
decreases expression |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8ap2 |
caspase 8 associated protein 2 |
|
affects expression |
EXP |
5 |
48,920,175 |
48,958,139 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
affects expression |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne2 |
cyclin E2 |
|
affects expression |
EXP |
5 |
25,032,748 |
25,044,509 |
RGD:6480464 |
CTD |
| G |
Ccnk |
cyclin K |
|
decreases expression |
ISO |
6 |
132,547,058 |
132,569,679 |
RGD:6480464 |
CTD |
| G |
Cdca7 |
cell division cycle associated 7 |
|
affects expression |
EXP |
3 |
54,948,493 |
54,959,128 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
affects expression |
EXP |
18 |
8,048,920 |
8,267,974 |
RGD:6480464 |
CTD |
| G |
Cdhr5 |
cadherin-related family member 5 |
|
affects expression |
EXP |
1 |
201,462,419 |
201,470,823 |
RGD:6480464 |
CTD |
| G |
Cdk14 |
cyclin-dependent kinase 14 |
|
affects expression |
EXP |
4 |
25,352,280 |
25,942,686 |
RGD:6480464 |
CTD |
| G |
Cdr2 |
cerebellar degeneration-related 2 |
|
affects expression |
EXP |
1 |
179,804,350 |
179,829,258 |
RGD:6480464 |
CTD |
| G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
|
affects expression |
EXP |
19 |
52,848,559 |
52,853,880 |
RGD:6480464 |
CTD |
| G |
Cenpm |
centromere protein M |
|
affects expression |
EXP |
7 |
120,607,395 |
120,619,299 |
RGD:6480464 |
CTD |
| G |
Cfh |
complement factor H |
|
affects expression |
EXP |
13 |
53,252,249 |
53,355,987 |
RGD:6480464 |
CTD |
| G |
Chaf1a |
chromatin assembly factor 1, subunit A (p150) |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Chaf1b |
chromatin assembly factor 1, subunit B (p60) |
|
affects expression |
EXP |
11 |
34,110,848 |
34,130,928 |
RGD:6480464 |
CTD |
| G |
Cideb |
cell death-inducing DFFA-like effector b |
|
affects expression |
EXP |
15 |
33,916,472 |
33,920,872 |
RGD:6480464 |
CTD |
| G |
Ckap2 |
cytoskeleton associated protein 2 |
|
affects expression |
EXP |
16 |
74,492,221 |
74,518,743 |
RGD:6480464 |
CTD |
| G |
Clic1 |
chloride intracellular channel 1 |
|
affects expression |
EXP |
20 |
3,498,935 |
3,842,500 |
RGD:6480464 |
CTD |
| G |
Clspn |
claspin |
|
affects expression |
EXP |
5 |
145,930,764 |
145,965,672 |
RGD:6480464 |
CTD |
| G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
affects expression |
EXP |
10 |
89,519,421 |
89,525,978 |
RGD:6480464 |
CTD |
| G |
Cntf |
ciliary neurotrophic factor |
|
affects expression |
EXP |
1 |
215,842,668 |
215,844,691 |
RGD:6480464 |
CTD |
| G |
Col18a1 |
collagen, type XVIII, alpha 1 |
|
affects expression |
EXP |
20 |
11,920,816 |
11,982,468 |
RGD:6480464 |
CTD |
| G |
Col4a2 |
collagen, type IV, alpha 2 |
|
decreases expression |
ISO |
16 |
82,899,206 |
83,045,102 |
RGD:6480464 |
CTD |
| G |
Cps1 |
carbamoyl-phosphate synthetase 1 |
|
affects expression |
EXP |
9 |
65,907,211 |
66,017,942 |
RGD:6480464 |
CTD |
| G |
Cpsf7 |
cleavage and polyadenylation specific factor 7 |
|
affects expression |
EXP |
1 |
213,009,572 |
213,032,612 |
RGD:6480464 |
CTD |
| G |
Ctnna1 |
catenin (cadherin-associated protein), alpha 1, 102kDa |
|
decreases expression |
ISO |
18 |
27,629,915 |
27,769,360 |
RGD:6480464 |
CTD |
| G |
Cutc |
cutC copper transporter homolog (E.coli) |
|
affects expression |
EXP |
1 |
247,062,300 |
247,077,070 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
decreases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c23 |
cytochrome P450, family 2, subfamily c, polypeptide 23 |
|
affects expression |
EXP |
1 |
249,204,049 |
249,228,689 |
RGD:6480464 |
CTD |
| G |
Cyp2d2 |
cytochrome P450, family 2, subfamily d, polypeptide 2 |
|
affects expression |
EXP |
7 |
120,796,210 |
120,800,279 |
RGD:6480464 |
CTD |
| G |
Cyp4f17 |
cytochrome P450, family 4, subfamily f, polypeptide 17 |
|
affects expression |
EXP |
7 |
13,095,557 |
13,111,638 |
RGD:6480464 |
CTD |
| G |
Dck |
deoxycytidine kinase |
|
affects expression |
EXP |
14 |
20,886,700 |
20,904,305 |
RGD:6480464 |
CTD |
| G |
Dcxr |
dicarbonyl L-xylulose reductase |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ddc |
dopa decarboxylase (aromatic L-amino acid decarboxylase) |
|
affects expression |
EXP |
14 |
92,698,636 |
92,788,635 |
RGD:6480464 |
CTD |
| G |
Ddx20 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 |
|
affects expression |
EXP |
2 |
200,929,985 |
200,937,976 |
RGD:6480464 |
CTD |
| G |
Dennd1a |
DENN/MADD domain containing 1A |
|
affects expression |
EXP |
3 |
17,561,878 |
17,996,342 |
RGD:6480464 |
CTD |
| G |
Deptor |
DEP domain containing MTOR-interacting protein |
|
affects expression |
EXP |
7 |
91,675,825 |
91,742,576 |
RGD:6480464 |
CTD |
| G |
Dis3l2 |
DIS3 mitotic control homolog (S. cerevisiae)-like 2 |
|
affects expression |
EXP |
9 |
85,470,810 |
85,855,679 |
RGD:6480464 |
CTD |
| G |
Dlx1 |
distal-less homeobox 1 |
|
affects expression |
EXP |
3 |
53,837,052 |
53,841,642 |
RGD:6480464 |
CTD |
| G |
Dnajb1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
decreases expression |
ISO |
19 |
26,213,739 |
26,217,480 |
RGD:6480464 |
CTD |
| G |
Dock1 |
dedicator of cyto-kinesis 1 |
|
affects expression |
EXP |
1 |
194,172,914 |
194,795,629 |
RGD:6480464 |
CTD |
| G |
Donson |
downstream neighbor of SON |
|
affects expression |
EXP |
11 |
31,652,219 |
31,661,872 |
RGD:6480464 |
CTD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
affects expression |
EXP |
2 |
214,931,901 |
215,818,809 |
RGD:6480464 |
CTD |
| G |
Dst |
dystonin |
|
affects expression |
EXP |
9 |
32,757,554 |
33,051,275 |
RGD:6480464 |
CTD |
| G |
Dusp12 |
dual specificity phosphatase 12 |
|
affects expression |
EXP |
13 |
86,737,093 |
86,746,186 |
RGD:6480464 |
CTD |
| G |
Dyrk3 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 |
|
affects expression |
EXP |
13 |
44,077,971 |
44,089,140 |
RGD:6480464 |
CTD |
| G |
E2f8 |
E2F transcription factor 8 |
|
affects expression |
EXP |
1 |
98,640,381 |
98,694,764 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
decreases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Elmo3 |
engulfment and cell motility 3 |
|
affects expression |
EXP |
19 |
35,119,813 |
35,124,187 |
RGD:6480464 |
CTD |
| G |
Emp1 |
epithelial membrane protein 1 |
|
affects expression |
EXP |
4 |
172,315,122 |
172,335,536 |
RGD:6480464 |
CTD |
| G |
Endod1 |
endonuclease domain containing 1 |
|
affects expression |
EXP |
8 |
11,151,051 |
11,180,463 |
RGD:6480464 |
CTD |
| G |
Epha2 |
Eph receptor A2 |
|
decreases expression |
ISO |
5 |
160,185,143 |
160,214,727 |
RGD:6480464 |
CTD |
| G |
Ercc6l |
excision repair cross-complementing rodent repair deficiency complementation group 6 - like |
|
affects expression |
EXP |
X |
90,195,080 |
90,212,006 |
RGD:6480464 |
CTD |
| G |
Etl4 |
enhancer trap locus 4 |
|
affects expression |
EXP |
17 |
94,757,415 |
94,770,668 |
RGD:6480464 |
CTD |
| G |
Exo1 |
exonuclease 1 |
|
affects expression |
EXP |
13 |
91,619,024 |
91,644,366 |
RGD:6480464 |
CTD |
| G |
Exoc4 |
exocyst complex component 4 |
|
affects expression |
EXP |
4 |
60,406,942 |
61,284,294 |
RGD:6480464 |
CTD |
| G |
Ezh2 |
enhancer of zeste homolog 2 (Drosophila) |
|
affects expression |
EXP |
4 |
75,709,959 |
75,773,279 |
RGD:6480464 |
CTD |
| G |
F10 |
coagulation factor X |
|
affects expression |
EXP |
16 |
81,327,237 |
81,346,544 |
RGD:6480464 |
CTD |
| G |
F5 |
coagulation factor V (proaccelerin, labile factor) |
|
affects expression |
EXP |
13 |
79,934,956 |
79,997,285 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
affects expression |
EXP |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fah |
fumarylacetoacetate hydrolase |
|
affects expression |
EXP |
1 |
140,851,975 |
140,876,187 |
RGD:6480464 |
CTD |
| G |
Fam111a |
family with sequence similarity 111, member A |
|
affects expression |
EXP |
1 |
215,581,410 |
215,597,220 |
RGD:6480464 |
CTD |
| G |
Fancb |
Fanconi anemia, complementation group B |
|
affects expression |
EXP |
X |
50,143,416 |
50,157,928 |
RGD:6480464 |
CTD |
| G |
Fbxo5 |
F-box protein 5 |
|
affects expression |
EXP |
1 |
36,492,134 |
36,498,503 |
RGD:6480464 |
CTD |
| G |
Fen1 |
flap structure-specific endonuclease 1 |
|
affects expression |
EXP |
1 |
212,688,118 |
212,692,486 |
RGD:6480464 |
CTD |
| G |
Fga |
fibrinogen alpha chain |
|
affects expression |
EXP |
2 |
174,737,640 |
174,753,598 |
RGD:6480464 |
CTD |
| G |
Fgfbp3 |
fibroblast growth factor binding protein 3 |
|
affects expression |
EXP |
1 |
241,188,007 |
241,190,012 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
decreases expression |
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Fhit |
fragile histidine triad |
|
affects expression |
EXP |
15 |
15,823,461 |
17,329,184 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
decreases expression |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Fosl2 |
fos-like antigen 2 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Foxq1 |
forkhead box Q1 |
|
affects expression |
EXP |
17 |
39,332,906 |
39,334,655 |
RGD:6480464 |
CTD |
| G |
Fubp1 |
far upstream element (FUSE) binding protein 1 |
|
affects expression |
EXP |
2 |
250,749,095 |
250,777,521 |
RGD:6480464 |
CTD |
| G |
Fzd8 |
frizzled family receptor 8 |
|
affects expression |
EXP |
17 |
65,968,739 |
65,971,724 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
affects expression |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
Galk1 |
galactokinase 1 |
|
affects expression |
EXP |
10 |
106,116,774 |
106,120,951 |
RGD:6480464 |
CTD |
| G |
Gbe1 |
glucan (1,4-alpha-), branching enzyme 1 |
|
affects expression |
EXP |
11 |
8,720,408 |
8,975,471 |
RGD:6480464 |
CTD |
| G |
Gca |
grancalcin |
|
affects expression |
EXP |
3 |
44,616,037 |
44,648,897 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
affects expression |
EXP |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Gins3 |
GINS complex subunit 3 (Psf3 homolog) |
|
affects expression |
EXP |
19 |
9,876,690 |
9,885,226 |
RGD:6480464 |
CTD |
| G |
Gli4 |
GLI family zinc finger 4 |
|
affects expression |
EXP |
7 |
113,579,245 |
113,584,458 |
RGD:6480464 |
CTD |
| G |
Glyctk |
glycerate kinase |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gmnn |
geminin |
|
affects expression |
EXP |
17 |
47,372,316 |
47,380,559 |
RGD:6480464 |
CTD |
| G |
Gpm6a |
glycoprotein m6a |
|
affects expression |
EXP |
16 |
39,670,748 |
39,783,384 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gstz1 |
glutathione S-transferase zeta 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gtdc1 |
glycosyltransferase-like domain containing 1 |
|
affects expression |
EXP |
3 |
25,042,343 |
25,345,382 |
RGD:6480464 |
CTD |
| G |
Gtse1 |
G-2 and S-phase expressed 1 |
|
affects expression |
EXP |
7 |
123,862,066 |
123,878,554 |
RGD:6480464 |
CTD |
| G |
Gulo |
gulonolactone (L-) oxidase |
|
affects expression |
EXP |
15 |
45,410,685 |
45,434,014 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
affects expression |
EXP |
7 |
30,520,913 |
30,551,145 |
RGD:6480464 |
CTD |
| G |
Hao1 |
hydroxyacid oxidase (glycolate oxidase) 1 |
|
decreases expression |
EXP |
3 |
122,506,916 |
122,564,012 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
affects expression |
EXP |
3 |
114,119,316 |
114,138,107 |
RGD:6480464 |
CTD |
| G |
Hdgf |
hepatoma-derived growth factor |
|
decreases expression |
ISO |
2 |
179,981,346 |
179,991,892 |
RGD:6480464 |
CTD |
| G |
Hgfac |
HGF activator |
|
affects expression |
EXP |
14 |
81,348,282 |
81,354,836 |
RGD:6480464 |
CTD |
| G |
Hirip3 |
HIRA interacting protein 3 |
|
affects expression |
EXP |
1 |
186,041,486 |
186,044,512 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
affects expression |
EXP |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
|
affects expression |
EXP |
7 |
142,150,229 |
142,154,520 |
RGD:6480464 |
CTD |
| G |
Hpdl |
4-hydroxyphenylpyruvate dioxygenase-like |
|
affects expression |
EXP |
5 |
137,116,378 |
137,117,984 |
RGD:6480464 |
CTD |
| G |
Hrsp12 |
heat-responsive protein 12 |
|
affects expression |
EXP |
7 |
69,930,464 |
69,944,267 |
RGD:6480464 |
CTD |
| G |
Hsd17b13 |
hydroxysteroid (17-beta) dehydrogenase 13 |
|
affects expression |
EXP |
14 |
6,901,197 |
6,915,871 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
decreases expression |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
decreases expression |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hyal2 |
hyaluronoglucosaminidase 2 |
|
decreases expression |
ISO |
8 |
112,817,001 |
112,820,693 |
RGD:6480464 |
CTD |
| G |
Hyi |
hydroxypyruvate isomerase |
|
affects expression |
EXP |
5 |
138,842,872 |
138,843,826 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
decreases expression |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Ier2 |
immediate early response 2 |
|
decreases expression |
ISO |
19 |
25,159,276 |
25,160,800 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
decreases expression |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ifi27l2b |
interferon, alpha-inducible protein 27 like 2B |
|
affects expression |
EXP |
6 |
127,733,540 |
127,735,026 |
RGD:6480464 |
CTD |
| G |
Igfbpl1 |
insulin-like growth factor binding protein-like 1 |
|
affects expression |
EXP |
5 |
62,324,324 |
62,339,729 |
RGD:6480464 |
CTD |
| G |
Igsf11 |
immunoglobulin superfamily, member 11 |
|
affects expression |
EXP |
11 |
63,501,592 |
63,640,441 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases expression |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Inadl |
InaD-like (Drosophila) |
|
affects expression |
EXP |
5 |
118,806,744 |
119,131,114 |
RGD:6480464 |
CTD |
| G |
Inip |
INTS3 and NABP interacting protein |
|
affects expression |
EXP |
5 |
77,890,067 |
77,901,083 |
RGD:6480464 |
CTD |
| G |
Iqub |
IQ motif and ubiquitin domain containing |
|
affects expression |
EXP |
4 |
50,903,801 |
50,948,991 |
RGD:6480464 |
CTD |
| G |
Itgb4 |
integrin, beta 4 |
|
decreases expression |
ISO |
10 |
106,080,452 |
106,116,632 |
RGD:6480464 |
CTD |
| G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
affects expression |
EXP |
16 |
6,319,608 |
6,334,782 |
RGD:6480464 |
CTD |
| G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
affects expression |
EXP |
4 |
143,705,360 |
144,030,051 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
affects response to substance |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kctd15 |
potassium channel tetramerisation domain containing 15 |
|
affects expression |
EXP |
1 |
87,117,385 |
87,130,690 |
RGD:6480464 |
CTD |
| G |
Kif12 |
kinesin family member 12 |
|
affects expression |
EXP |
5 |
80,146,349 |
80,152,996 |
RGD:6480464 |
CTD |
| G |
Kif16b |
kinesin family member 16B |
|
affects expression |
EXP |
3 |
130,967,515 |
131,250,402 |
RGD:6480464 |
CTD |
| G |
Kif18b |
kinesin family member 18B |
|
affects expression |
EXP |
10 |
92,077,414 |
92,096,586 |
RGD:6480464 |
CTD |
| G |
Kif22 |
kinesin family member 22 |
|
affects expression |
EXP |
1 |
186,205,162 |
186,293,437 |
RGD:6480464 |
CTD |
| G |
Klf5 |
Kruppel-like factor 5 |
|
affects expression |
EXP |
15 |
83,103,177 |
83,118,363 |
RGD:6480464 |
CTD |
| G |
Klhl21 |
kelch-like family member 21 |
|
affects expression |
EXP |
5 |
169,236,427 |
169,246,001 |
RGD:6480464 |
CTD |
| G |
Lama2 |
laminin, alpha 2 |
|
affects expression |
EXP |
1 |
18,203,466 |
18,885,462 |
RGD:6480464 |
CTD |
| G |
Lgals2 |
lectin, galactoside-binding, soluble, 2 |
|
affects expression |
EXP |
7 |
116,811,332 |
116,817,822 |
RGD:6480464 |
CTD |
| G |
Lhx2 |
LIM homeobox 2 |
|
affects expression |
EXP |
3 |
18,129,455 |
18,147,357 |
RGD:6480464 |
CTD |
| G |
Lig1 |
ligase I, DNA, ATP-dependent |
|
increases expression |
EXP |
1 |
73,728,892 |
73,767,429 |
RGD:6480464 |
CTD |
| G |
Lin54 |
lin-54 homolog (C. elegans) |
|
affects expression |
EXP |
14 |
10,398,080 |
10,439,960 |
RGD:6480464 |
CTD |
| G |
Lin7c |
lin-7 homolog C (C. elegans) |
|
affects expression |
EXP |
3 |
95,327,942 |
95,335,254 |
RGD:6480464 |
CTD |
| G |
Lmnb2 |
lamin B2 |
|
affects expression |
EXP |
7 |
10,303,626 |
10,326,068 |
RGD:6480464 |
CTD |
| G |
Loxl2 |
lysyl oxidase-like 2 |
|
affects expression |
EXP |
15 |
49,982,103 |
50,068,902 |
RGD:6480464 |
CTD |
| G |
Lrba |
LPS-responsive vesicle trafficking, beach and anchor containing |
|
affects expression |
EXP |
2 |
178,257,272 |
178,787,626 |
RGD:6480464 |
CTD |
| G |
Lrrfip1 |
leucine rich repeat (in FLII) interacting protein 1 |
|
affects expression |
EXP |
9 |
90,278,891 |
90,346,980 |
RGD:6480464 |
CTD |
| G |
Lyar |
Ly1 antibody reactive |
|
affects expression |
EXP |
14 |
77,859,637 |
77,873,205 |
RGD:6480464 |
CTD |
| G |
Maff |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
|
affects expression |
EXP |
7 |
117,328,924 |
117,340,276 |
RGD:6480464 |
CTD |
| G |
Man1a1 |
mannosidase, alpha, class 1A, member 1 |
|
affects expression |
EXP |
20 |
32,582,507 |
32,766,761 |
RGD:6480464 |
CTD |
| G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
|
affects expression |
EXP |
10 |
99,859,684 |
99,974,446 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
affects response to substance |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
affects response to substance |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapkapk2 |
mitogen-activated protein kinase-activated protein kinase 2 |
|
decreases expression |
ISO |
13 |
43,994,943 |
44,041,504 |
RGD:6480464 |
CTD |
| G |
Marcksl1 |
MARCKS-like 1 |
|
decreases expression |
ISO |
5 |
148,669,499 |
148,672,337 |
RGD:6480464 |
CTD |
| G |
Mcm10 |
minichromosome maintenance complex component 10 |
|
affects expression |
EXP |
17 |
84,354,481 |
84,375,749 |
RGD:6480464 |
CTD |
| G |
Mcm2 |
minichromosome maintenance complex component 2 |
|
affects expression |
EXP |
4 |
122,977,522 |
122,991,934 |
RGD:6480464 |
CTD |
| G |
Mcm3 |
minichromosome maintenance complex component 3 |
|
affects expression |
EXP |
9 |
19,536,922 |
19,554,871 |
RGD:6480464 |
CTD |
| G |
Mcm4 |
minichromosome maintenance complex component 4 |
|
affects expression |
EXP |
11 |
87,169,742 |
87,183,443 |
RGD:6480464 |
CTD |
| G |
Mcm5 |
minichromosome maintenance complex component 5 |
|
affects expression |
EXP |
19 |
13,978,940 |
14,000,641 |
RGD:6480464 |
CTD |
| G |
Mcm6 |
minichromosome maintenance complex component 6 |
|
affects expression |
EXP |
13 |
41,045,677 |
41,070,868 |
RGD:6480464 |
CTD |
| G |
Mcm7 |
minichromosome maintenance complex component 7 |
|
affects expression |
EXP |
12 |
17,607,250 |
17,614,508 |
RGD:6480464 |
CTD |
| G |
Mcm8 |
minichromosome maintenance complex component 8 |
|
affects expression |
EXP |
3 |
120,614,429 |
120,644,673 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
affects expression |
EXP |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mex3b |
mex3 homolog B (C. elegans) |
|
affects expression |
EXP |
1 |
139,135,572 |
139,139,807 |
RGD:6480464 |
CTD |
| G |
Mis18a |
MIS18 kinetochore protein homolog A (S. pombe) |
|
affects expression |
EXP |
11 |
30,695,856 |
30,708,888 |
RGD:6480464 |
CTD |
| G |
Mlf1ip |
MLF1 interacting protein |
|
affects expression |
EXP |
16 |
48,997,465 |
49,020,684 |
RGD:6480464 |
CTD |
| G |
Mms22l |
MMS22-like, DNA repair protein |
|
affects expression |
EXP |
5 |
39,528,968 |
39,645,371 |
RGD:6480464 |
CTD |
| G |
Msantd3 |
Myb/SANT-like DNA-binding domain containing 3 |
|
affects expression |
EXP |
5 |
65,226,927 |
65,249,757 |
RGD:6480464 |
CTD |
| G |
Msi2 |
musashi RNA-binding protein 2 |
|
affects expression |
EXP |
10 |
76,776,415 |
77,149,277 |
RGD:6480464 |
CTD |
| G |
Mst1 |
Macrophage stimulating 1 (hepatocyte growth factor-like) |
|
affects expression |
EXP |
8 |
113,348,203 |
113,352,773 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
affects expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
affects expression |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mybl2 |
myeloblastosis oncogene-like 2 |
|
affects expression |
EXP |
3 |
153,925,908 |
153,954,323 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myo1g |
myosin IG |
|
affects expression |
EXP |
14 |
87,275,457 |
87,290,598 |
RGD:6480464 |
CTD |
| G |
Myof |
myoferlin |
|
affects expression |
EXP |
1 |
242,209,178 |
242,372,206 |
RGD:6480464 |
CTD |
| G |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated 9 |
|
affects expression |
EXP |
17 |
29,304,750 |
29,354,613 |
RGD:6480464 |
CTD |
| G |
Ngef |
neuronal guanine nucleotide exchange factor |
|
affects expression |
EXP |
9 |
86,294,206 |
86,327,765 |
RGD:6480464 |
CTD |
| G |
Nupr1 |
nuclear protein, transcriptional regulator, 1 |
|
affects expression |
EXP |
1 |
185,770,310 |
185,772,313 |
RGD:6480464 |
CTD |
| G |
Opn3 |
opsin 3 |
|
affects expression |
EXP |
13 |
91,396,311 |
91,427,005 |
RGD:6480464 |
CTD |
| G |
Orc1 |
origin recognition complex, subunit 1 |
|
affects expression |
EXP |
5 |
129,881,973 |
129,901,675 |
RGD:6480464 |
CTD |
| G |
Orc6 |
origin recognition complex, subunit 6 |
|
affects expression |
EXP |
19 |
23,116,888 |
23,124,657 |
RGD:6480464 |
CTD |
| G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
|
affects expression |
EXP |
19 |
49,675,215 |
49,690,479 |
RGD:6480464 |
CTD |
| G |
Pah |
phenylalanine hydroxylase |
|
affects expression |
EXP |
7 |
24,175,898 |
24,243,592 |
RGD:6480464 |
CTD |
| G |
Pcca |
propionyl CoA carboxylase, alpha polypeptide |
|
affects expression |
EXP |
15 |
107,659,723 |
108,028,929 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Phf20l1 |
PHD finger protein 20-like 1 |
|
affects expression |
EXP |
7 |
103,945,838 |
103,976,140 |
RGD:6480464 |
CTD |
| G |
Phlda1 |
pleckstrin homology-like domain, family A, member 1 |
|
affects expression |
EXP |
7 |
50,541,011 |
50,543,215 |
RGD:6480464 |
CTD |
| G |
Phlda3 |
pleckstrin homology-like domain, family A, member 3 |
|
affects expression |
EXP |
13 |
48,789,678 |
48,793,999 |
RGD:6480464 |
CTD |
| G |
Pik3c2g |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma |
|
affects expression |
EXP |
4 |
176,712,201 |
177,074,095 |
RGD:6480464 |
CTD |
| G |
Pla2r1 |
phospholipase A2 receptor 1 |
|
affects expression |
EXP |
3 |
42,121,966 |
42,250,869 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
decreases expression |
ISO |
1 |
79,708,646 |
79,712,881 |
RGD:6480464 |
CTD |
| G |
Plcb1 |
phospholipase C, beta 1 (phosphoinositide-specific) |
|
affects expression |
EXP |
3 |
122,797,718 |
123,523,675 |
RGD:6480464 |
CTD |
| G |
Plg |
plasminogen |
|
affects expression |
EXP |
1 |
42,782,464 |
42,825,149 |
RGD:6480464 |
CTD |
| G |
Plk4 |
polo-like kinase 4 |
|
affects expression |
EXP |
2 |
127,760,508 |
127,779,640 |
RGD:6480464 |
CTD |
| G |
Pola2 |
polymerase (DNA directed), alpha 2, accessory subunit |
|
affects expression |
EXP |
1 |
208,573,153 |
208,597,195 |
RGD:6480464 |
CTD |
| G |
Pold1 |
polymerase (DNA directed), delta 1, catalytic subunit |
|
increases expression |
EXP |
1 |
95,010,719 |
95,021,686 |
RGD:6480464 |
CTD |
| G |
Pold2 |
polymerase (DNA directed), delta 2, accessory subunit |
|
increases expression |
EXP |
14 |
86,535,757 |
86,541,920 |
RGD:6480464 |
CTD |
| G |
Pole |
polymerase (DNA directed), epsilon, catalytic subunit |
|
increases expression |
EXP |
12 |
46,491,498 |
46,539,988 |
RGD:6480464 |
CTD |
| G |
Pole2 |
polymerase (DNA directed), epsilon 2, accessory subunit |
|
increases expression |
EXP |
6 |
91,155,518 |
91,180,121 |
RGD:6480464 |
CTD |
| G |
Pon3 |
paraoxonase 3 |
|
affects expression |
EXP |
4 |
30,000,505 |
30,027,203 |
RGD:6480464 |
CTD |
| G |
Ppap2b |
phosphatidic acid phosphatase type 2B |
|
affects expression |
EXP |
5 |
126,121,416 |
126,197,099 |
RGD:6480464 |
CTD |
| G |
Ppp1ca |
protein phosphatase 1, catalytic subunit, alpha isozyme |
|
decreases expression |
ISO |
1 |
206,774,719 |
206,778,336 |
RGD:6480464 |
CTD |
| G |
Prkrir |
protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor) |
|
affects expression |
EXP |
1 |
155,982,782 |
155,998,561 |
RGD:6480464 |
CTD |
| G |
Psrc1 |
proline/serine-rich coiled-coil 1 |
|
affects expression |
EXP |
2 |
203,952,299 |
203,956,742 |
RGD:6480464 |
CTD |
| G |
Ptges2 |
prostaglandin E synthase 2 |
|
affects expression |
EXP |
3 |
11,521,214 |
11,528,395 |
RGD:6480464 |
CTD |
| G |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
|
affects expression |
EXP |
15 |
14,449,352 |
15,130,760 |
RGD:6480464 |
CTD |
| G |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
|
affects expression |
EXP |
1 |
17,328,563 |
17,752,200 |
RGD:6480464 |
CTD |
| G |
Pzp |
pregnancy-zone protein |
|
affects expression |
EXP |
4 |
165,505,104 |
165,579,027 |
RGD:6480464 |
CTD |
| G |
Rabgap1l |
RAB GTPase activating protein 1-like |
|
affects expression |
EXP |
13 |
75,685,603 |
76,275,726 |
RGD:6480464 |
CTD |
| G |
Rad51 |
RAD51 homolog (S. cerevisiae) |
|
affects expression |
EXP |
3 |
105,625,265 |
105,650,392 |
RGD:6480464 |
CTD |
| G |
Rad51ap1 |
RAD51 associated protein 1 |
|
affects expression |
EXP |
4 |
163,308,788 |
163,321,854 |
RGD:6480464 |
CTD |
| G |
Rapgef4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
|
affects expression |
EXP |
3 |
54,396,312 |
54,717,148 |
RGD:6480464 |
CTD |
| G |
Rbbp7 |
retinoblastoma binding protein 7 |
|
increases expression |
ISO |
X |
52,669,703 |
52,688,332 |
RGD:6480464 |
CTD |
| G |
Rfc4 |
replication factor C (activator 1) 4 |
|
decreases expression |
ISO |
11 |
79,935,273 |
79,950,589 |
RGD:6480464 |
CTD |
| G |
Rfwd3 |
ring finger and WD repeat domain 3 |
|
affects expression |
EXP |
19 |
41,190,144 |
41,222,888 |
RGD:6480464 |
CTD |
| G |
RGD1303142 |
oxidative stress responsive gene |
|
affects expression |
EXP |
3 |
154,298,274 |
154,316,430 |
RGD:6480464 |
CTD |
| G |
RGD1305807 |
hypothetical LOC298077 |
|
affects expression |
EXP |
5 |
62,354,979 |
62,395,472 |
RGD:6480464 |
CTD |
| G |
RGD1310495 |
similar to KIAA1919 protein |
|
affects expression |
EXP |
20 |
44,188,511 |
44,203,154 |
RGD:6480464 |
CTD |
| G |
RGD1559600 |
RGD1559600 |
|
affects expression |
EXP |
1 |
177,887,740 |
177,899,508 |
RGD:6480464 |
CTD |
| G |
RGD1559690 |
similar to hypothetical protein FLJ25416 |
|
affects expression |
EXP |
1 |
149,685,954 |
149,710,264 |
RGD:6480464 |
CTD |
| G |
RGD1560010 |
RGD1560010 |
|
affects expression |
EXP |
2 |
171,031,075 |
171,034,207 |
RGD:6480464 |
CTD |
| G |
RGD1565709 |
similar to ovostatin-2 |
|
affects expression |
EXP |
4 |
165,560,839 |
165,603,598 |
RGD:6480464 |
CTD |
| G |
Rgn |
regucalcin (senescence marker protein-30) |
|
affects expression |
EXP |
X |
13,037,171 |
13,052,846 |
RGD:6480464 |
CTD |
| G |
Rpa2 |
replication protein A2 |
|
increases expression |
EXP |
5 |
152,369,550 |
152,380,370 |
RGD:6480464 |
CTD |
| G |
Rps3a |
ribosomal protein S3a |
|
increases expression |
ISO |
2 |
178,092,351 |
178,096,720 |
RGD:6480464 |
CTD |
| G |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
|
decreases expression |
ISO |
5 |
151,274,666 |
151,288,007 |
RGD:6480464 |
CTD |
| G |
Rrm1-ps1 |
ribonucleotide reductase M1, pseudogene 1 |
|
affects expression |
EXP |
14 |
77,408,781 |
77,411,150 |
RGD:6480464 |
CTD |
| G |
Rrm2 |
ribonucleotide reductase M2 |
|
affects expression |
EXP |
6 |
42,350,541 |
42,356,748 |
RGD:6480464 |
CTD |
| G |
Samd4a |
sterile alpha motif domain containing 4A |
|
affects expression |
EXP |
15 |
22,847,701 |
22,952,499 |
RGD:6480464 |
CTD |
| G |
Senp7 |
SUMO1/sentrin specific peptidase 7 |
|
affects expression |
EXP |
11 |
45,390,458 |
45,539,624 |
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
affects expression |
EXP |
2 |
52,451,883 |
52,462,263 |
RGD:6480464 |
CTD |
| G |
Sept4 |
septin 4 |
|
affects expression |
EXP |
10 |
75,871,422 |
75,880,878 |
RGD:6480464 |
CTD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
decreases expression |
ISO |
6 |
127,998,617 |
128,021,719 |
RGD:6480464 |
CTD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
affects expression |
EXP |
6 |
127,998,617 |
128,021,719 |
RGD:6480464 |
CTD |
| G |
Serpina3n |
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
|
affects expression |
EXP |
6 |
128,461,775 |
128,469,309 |
RGD:6480464 |
CTD |
| G |
Serpind1 |
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
|
affects expression |
EXP |
11 |
85,666,714 |
85,677,716 |
RGD:6480464 |
CTD |
| G |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
|
affects expression |
EXP |
1 |
204,399,856 |
204,855,474 |
RGD:6480464 |
CTD |
| G |
Skp2 |
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
|
affects expression |
EXP |
2 |
58,769,164 |
58,797,229 |
RGD:6480464 |
CTD |
| G |
Slc22a18 |
solute carrier family 22, member 18 |
|
affects expression |
EXP |
1 |
203,852,313 |
203,876,165 |
RGD:6480464 |
CTD |
| G |
Slc22a23 |
solute carrier family 22, member 23 |
|
affects expression |
EXP |
17 |
36,883,334 |
37,049,975 |
RGD:6480464 |
CTD |
| G |
Slc25a21 |
solute carrier family 25 (mitochondrial oxoadipate carrier), member 21 |
|
affects expression |
EXP |
6 |
77,124,451 |
77,632,510 |
RGD:6480464 |
CTD |
| G |
Slc25a23 |
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
decreases expression |
ISO |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
affects expression |
EXP |
2 |
116,036,501 |
116,065,834 |
RGD:6480464 |
CTD |
| G |
Slc48a1 |
solute carrier family 48 (heme transporter), member 1 |
|
affects expression |
EXP |
7 |
136,492,421 |
136,500,222 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
affects expression |
EXP |
2 |
139,241,142 |
139,317,101 |
RGD:6480464 |
CTD |
| G |
Slc7a7 |
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
|
affects expression |
EXP |
15 |
32,431,748 |
32,471,526 |
RGD:6480464 |
CTD |
| G |
Slfn13 |
schlafen family member 13 |
|
affects expression |
EXP |
10 |
71,192,184 |
71,205,605 |
RGD:6480464 |
CTD |
| G |
Smoc1 |
SPARC related modular calcium binding 1 |
|
affects expression |
EXP |
6 |
104,825,269 |
104,998,689 |
RGD:6480464 |
CTD |
| G |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
|
affects expression |
EXP |
4 |
55,350,745 |
55,761,185 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
decreases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
increases activity |
ISO |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Spata5l1 |
spermatogenesis associated 5-like 1 |
|
affects expression |
EXP |
3 |
109,584,705 |
109,597,704 |
RGD:6480464 |
CTD |
| G |
Sqstm1 |
sequestosome 1 |
|
increases expression |
EXP |
10 |
35,751,300 |
35,762,630 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
affects expression |
EXP |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Stard13 |
StAR-related lipid transfer (START) domain containing 13 |
|
affects expression |
EXP |
12 |
3,502,402 |
3,696,144 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
affects expression |
EXP |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Suv39h2 |
suppressor of variegation 3-9 homolog 2 (Drosophila) |
|
affects expression |
EXP |
17 |
85,875,954 |
85,894,979 |
RGD:6480464 |
CTD |
| G |
Syne1 |
spectrin repeat containing, nuclear envelope 1 |
|
affects expression |
EXP |
1 |
35,803,552 |
36,269,628 |
RGD:6480464 |
CTD |
| G |
Taf1d |
TATA box binding protein (Tbp)-associated factor, RNA polymerase I, D |
|
affects expression |
EXP |
8 |
12,107,144 |
12,117,177 |
RGD:6480464 |
CTD |
| G |
Taldo1 |
transaldolase 1 |
|
affects expression |
EXP |
1 |
201,582,856 |
201,593,187 |
RGD:6480464 |
CTD |
| G |
Tat |
tyrosine aminotransferase |
|
affects expression |
EXP |
19 |
39,854,163 |
39,865,060 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnk1 |
tyrosine kinase, non-receptor, 1 |
|
decreases expression |
ISO |
10 |
56,692,319 |
56,698,602 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
affects response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Trrap |
transformation/transcription domain-associated protein |
|
decreases expression |
ISO |
12 |
10,054,055 |
10,143,736 |
RGD:6480464 |
CTD |
| G |
Ttr |
transthyretin |
|
affects expression |
EXP |
18 |
12,406,571 |
12,413,680 |
RGD:6480464 |
CTD |
| G |
Tubb2a |
tubulin, beta 2A class IIa |
|
affects expression |
EXP |
17 |
37,139,177 |
37,143,049 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
affects expression |
EXP |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Uap1l1 |
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 |
|
affects expression |
EXP |
3 |
3,526,396 |
3,531,669 |
RGD:6480464 |
CTD |
| G |
Ubc |
ubiquitin C |
|
increases expression |
ISO |
12 |
32,333,211 |
32,337,944 |
RGD:6480464 |
CTD |
| G |
Ube2t |
ubiquitin-conjugating enzyme E2T (putative) |
|
affects expression |
EXP |
13 |
47,924,340 |
47,934,842 |
RGD:6480464 |
CTD |
| G |
Uchl5 |
ubiquitin carboxyl-terminal hydrolase L5 |
|
affects expression |
EXP |
13 |
57,605,912 |
57,643,050 |
RGD:6480464 |
CTD |
| G |
Ugt2b7 |
UDP glucuronosyltransferase 2 family, polypeptide B7 |
|
affects expression |
EXP |
14 |
22,499,152 |
22,522,842 |
RGD:6480464 |
CTD |
| G |
Uhrf1 |
ubiquitin-like with PHD and ring finger domains 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Uox |
urate oxidase |
|
affects expression |
EXP |
2 |
244,795,552 |
244,832,143 |
RGD:6480464 |
CTD |
| G |
Usp1 |
ubiquitin specific peptidase 1 |
|
affects expression |
EXP |
5 |
119,364,515 |
119,375,885 |
RGD:6480464 |
CTD |
| G |
UST4r |
integral membrane transport protein UST4r |
|
affects expression |
EXP |
1 |
210,618,706 |
210,688,125 |
RGD:6480464 |
CTD |
| G |
Utrn |
utrophin |
|
affects expression |
EXP |
1 |
7,099,840 |
7,614,980 |
RGD:6480464 |
CTD |
| G |
Vezf1 |
vascular endothelial zinc finger 1 |
|
decreases expression |
ISO |
10 |
76,364,360 |
76,374,956 |
RGD:6480464 |
CTD |
| G |
Vil1 |
villin 1 |
|
affects expression |
EXP |
9 |
73,748,632 |
73,776,347 |
RGD:6480464 |
CTD |
| G |
Vps13b |
vacuolar protein sorting 13 homolog B (yeast) |
|
affects expression |
EXP |
7 |
70,839,616 |
71,464,951 |
RGD:6480464 |
CTD |
| G |
Vwa8 |
von Willebrand factor A domain containing 8 |
|
affects expression |
EXP |
15 |
59,993,882 |
60,364,838 |
RGD:6480464 |
CTD |
| G |
Wee1 |
wee 1 homolog (S. pombe) |
|
affects expression |
EXP |
1 |
167,769,797 |
167,788,199 |
RGD:6480464 |
CTD |
| G |
Wnk4 |
WNK lysine deficient protein kinase 4 |
|
affects expression |
EXP |
10 |
90,289,273 |
90,306,225 |
RGD:6480464 |
CTD |
| G |
Ybx1 |
Y box binding protein 1 |
|
increases activity |
EXP |
5 |
139,859,176 |
139,875,840 |
RGD:6480464 |
CTD |
| G |
Ybx1 |
Y box binding protein 1 |
|
increases activity |
ISO |
5 |
139,859,176 |
139,875,840 |
RGD:6480464 |
CTD |
| G |
Ywhah |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide |
|
decreases expression |
ISO |
14 |
83,448,395 |
83,457,778 |
RGD:6480464 |
CTD |
| G |
Zfand2a |
zinc finger, AN1-type domain 2A |
|
affects expression |
EXP |
12 |
15,661,609 |
15,672,672 |
RGD:6480464 |
CTD |
| G |
Zfp367 |
zinc finger protein 367 |
|
affects expression |
EXP |
17 |
6,492,142 |
6,511,271 |
RGD:6480464 |
CTD |
| G |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
|
decreases expression |
ISO |
6 |
103,119,555 |
103,124,576 |
RGD:6480464 |
CTD |
| G |
Zyx |
zyxin |
|
decreases expression |
ISO |
4 |
70,119,162 |
70,128,016 |
RGD:6480464 |
CTD |
sodium hydrogencarbonate
|
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Slc39a8 |
solute carrier family 39 (zinc transporter), member 8 |
|
multiple interactions |
EXP |
2 |
233,340,397 |
233,403,461 |
RGD:6480464 |
CTD |
| G |
Slc4a4 |
solute carrier family 4, sodium bicarbonate cotransporter, member 4 |
|
increases transport |
ISO |
14 |
20,381,545 |
20,739,216 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
multiple interactions |
EXP |
17 |
87,847,280 |
87,855,763 |
RGD:6480464 |
CTD |
sodium hydrogensulfite
|
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Ptger2 |
prostaglandin E receptor 2 (subtype EP2) |
|
multiple interactions |
EXP |
15 |
20,205,443 |
20,216,872 |
RGD:6480464 |
CTD |
| G |
Ptger4 |
prostaglandin E receptor 4 (subtype EP4) |
|
multiple interactions |
EXP |
2 |
54,423,280 |
54,433,907 |
RGD:6480464 |
CTD |
| G |
Ptges |
prostaglandin E synthase |
|
multiple interactions |
EXP |
3 |
9,946,194 |
9,957,538 |
RGD:6480464 |
CTD |
| G |
Ptges2 |
prostaglandin E synthase 2 |
|
multiple interactions |
EXP |
3 |
11,521,214 |
11,528,395 |
RGD:6480464 |
CTD |
| G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
multiple interactions |
EXP |
3 |
15,343,832 |
15,365,412 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
sodium iodide
|
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
affects export |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
decreases export |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
increases abundance |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
increases uptake |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
increases uptake |
EXP |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
increases activity |
EXP |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
EXP |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
decreases export |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
increases uptake |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
increases uptake |
EXP |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
EXP |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
increases uptake |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
increases uptake |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
increases uptake |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
increases uptake |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
increases uptake |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
| G |
Tpo |
thyroid peroxidase |
|
multiple interactions |
ISO |
6 |
47,954,848 |
48,025,740 |
RGD:6480464 |
CTD |
sodium phosphate
|
| G |
Ppa1 |
pyrophosphatase (inorganic) 1 |
|
increases hydrolysis |
ISO |
20 |
29,015,647 |
29,042,399 |
RGD:6480464 |
CTD |
sodium thiocyanate
|
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
tartrazine
|
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases activity |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
multiple interactions |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
increases expression |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
Term paths to the root
|